Cancer immunology is a field of study that focuses on understanding the interactions between the immune system and cancer cells. The immune system plays a crucial role in recognizing and eliminating abnormal cells, including cancerous ones. Research in cancer immunology aims to decipher the complex interplay between cancer and the immune system. Key concepts include immunosurveillance, which describes the immune system's ability to recognize and eliminate cancer cells, and immune evasion, where tumors develop strategies to escape immune responses. Immunotherapies have emerged as a groundbreaking approach in cancer treatment, leveraging the body's immune system to target and destroy cancer cells. Checkpoint inhibitors, adoptive cell therapies, and cancer vaccines are among the innovative immunotherapeutic strategies being developed to enhance immune responses against cancer. Understanding the tumor microenvironment, immune cell activation, and the role of immunosuppressive factors are critical in advancing cancer immunology. Ongoing research in this field holds promise for the development of more effective and personalized immunotherapies, revolutionizing cancer treatment and improving patient outcomes.
Title : Prophylactic and molecular approaches for mitigating human influenza A viruses: i. Evaluating influenza vaccine effectiveness in the older population ii. Down-regulation of influenza virus genes with novel sirna-chimeric-ribozyme constructs
Madhu Khanna, University of Delhi, India
Title : Homology analysis of MPXV and VACV peptides underscores the need to consider both MPXV clades for vaccine development
Lara Isis Teodoro, Mayo Clinic, United States
Title : High seroprevalence of RSV antibodies in adults indicates potential undetected transmission and requires further public health assessment
Lara Isis Teodoro, Mayo Clinic, United States
Title : A promising novel approach to DNA vaccines
Khursheed Anwer, IMUNON, United States
Title : The role of immunity in the pathogenesis of SARS-COV-2 and in the protection generated by COVID-19 in different age groups
Ahmed Abdulazeez, BHRUT Trust, United Kingdom
Title : Development of a novel multi-component vaccine to address the burden of otitis media in high-risk populations
Ayesha Zahid, Griffith University, Australia
Title : Tubercular disease in children: Optimizing treatment strategies through disease insights
Elena Chiappini, University of Florence, Italy
Title : New biomarkers in leishmania major vaccine development
Negar Seyed, Pasteur Institute of Iran, Iran (Islamic Republic of)
Title : Racial disparities in pediatric pneumonia in Brazil: The role of structural racism forging inequalities in acess to vaccines
Livia Daflon Silva, Federal University of State of Rio de Janeiro, Brazil
Title : Approaches towards developing and establishing a biomanufacturing research & development, and manufacturing industry in Zimbabwe: A review of the need, potential funding sources, policy development and implementation
Elliot Nyagumbo, Midlands State University, Zimbabwe